Adjunctive Intracoronary Infusion of Antithrombin III During Percutaneous Transluminal Coronary Angioplasty. Results of a Prospective, Randomized Trial

Circulation - United States
doi 10.1161/01.cir.90.5.2258
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Acute Coronary Occlusion During Percutaneous Transluminal Coronary Angioplasty.

Heart
Cardiovascular MedicineCardiology
1985English

Normalization of Coronary Vasomotion After Percutaneous Transluminal Coronary Angioplasty?

Circulation
Cardiovascular MedicinePhysiologyCardiology
1992English

Efficacy of Percutaneous Transluminal Coronary Angioplasty in Patients With Acute Myocardial Infarction. Comparison With Intracoronary Thrombolysis.

Japanese Circulation Journal
1988English

Assessment of Immediate and Long-Term Functional Results of Percutaneous Transluminal Coronary Angioplasty

Circulation
Cardiovascular MedicinePhysiologyCardiology
1988English

Surgical Cover for Percutaneous Transluminal Coronary Angioplasty

Heart
Cardiovascular MedicineCardiology
1992English

Cerebral Venous Thrombosis Along With Antithrombin III Deficiency Successfully Treated Using Percutaneous Transluminal Angioplasty: A Case Report

Nosotchu
2011English

A Prospective Controlled Trial on Effect of Percutaneous Transluminal Angioplasty on Functioning Arteriovenous Fistulae Survival

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2003English

Percutaneous Transluminal Angioplasty

American Journal of Roentgenology
MedicineNuclear MedicineRadiologyImaging
1981English

Acute Complications of Percutaneous Transluminal Coronary Angioplasty for Total Occlusion

American Heart Journal
Cardiovascular MedicineCardiology
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy